Verastem (VSTM) EBITDA Margin (2018 - 2026)

Verastem (VSTM) recorded quarterly EBITDA Margin of 177.83% in Q1 2026, down 24.02% quarter-over-quarter from 143.38% in Q4 2025.

Verastem (VSTM) EBITDA Margin (2018 - 2026) Analysis & Trends

Verastem's EBITDA Margin history runs 8 years deep, the most recent figure standing at 177.83% for Q1 2026.

  • In Q1 2026, EBITDA Margin changed N/A year-over-year to 177.83%; the TTM figure through Mar 2026 stood at 360.4% (changed N/A YoY), while the FY2025 annual figure was 660.68%, up 64582.0% from the prior year.
  • EBITDA Margin was 177.83% for Q1 2026 at Verastem, down from 143.38% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 82.52% in Q2 2024 to a low of 1150.44% in Q2 2025.
  • Historically, EBITDA Margin has averaged 510.86% across 4 years, with a median of 418.44% in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 83697 bps in 2022, then slumped 106792 bps in 2025.
  • A 4-year view of EBITDA Margin shows it stood at 659.05% in 2022, then soared by 87 bps to 82.52% in 2024, then slumped by 74 bps to 143.38% in 2025, then slipped by 24 bps to 177.83% in 2026.
  • The last three EBITDA Margin figures came in at 177.83% (Q1 2026), 143.38% (Q4 2025), and 851.92% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -177.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 -177.83%
Dec 31, 2025 -143.38%
Sep 30, 2025 -851.92%
Jun 30, 2025 -1,150.44%
Jun 30, 2024 -82.52%
Mar 31, 2022 -659.05%
Dec 31, 2021 -3,022.75%
Sep 30, 2021 -1,139,900.00%
Jun 30, 2021 -3,379.40%
Mar 31, 2021 -1,496.02%
Dec 31, 2020 -3,915.22%
Sep 30, 2020 16.71%
Jun 30, 2020 -534.46%
Mar 31, 2020 -751.48%
Dec 31, 2019 -1,072.35%
Sep 30, 2019 -334.34%
Jun 30, 2019 -1,346.24%
Mar 31, 2019 -2,281.21%
Dec 31, 2018 -927.60%
Sep 30, 2018 -139.73%